Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1997-12-1
|
pubmed:abstractText |
Enhancement of in vivo antiviral activity of 5,7,4'-trihydroxy-8-methoxyflavone (F36) against H3N2 subtype of influenza A virus by drug delivery system (DDS) with hydroxypropyl cellulose (HPC) was studied. Although in the absence of HPC F36 (0.5 mg/kg) showed no antiviral activity against mouse-adapted influenza virus A/Guizhou/54/89 (H3N2) in mice, when F36 solution containing HPC was administered intranasally 5 min after the virus inoculation, proliferation of the virus in both nasal and broncho-alveolar cavities was inhibited significantly. The relationship between concentration (0.2-0.5%) and deposition ratio of HPC was studied. When 10 microliters of fluorescein isothiocyanate (FITC)-conjugated HPC solution was administered intranasally to BALB/c mice, deposition ratio of HPC at 6 h after inoculation in nasal cavity was dependent on its concentration. The deposition ratio of HPC in broncho-alveolar cavity, however, was reversely dependent on its concentration. Anti-influenza virus activity of F36 in nasal and broncho-alveolar cavities was dependent both on the concentration and deposition ratio of HPC. HPC was most effective at 0.5% in nasal cavity and at 0.3% in broncho-alveolar cavity. These results indicate that DDS with HPC enhances the anti-influenza virus activity of F36 in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/5,7,4'-trihydroxy-8-methoxyflavone,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cellulose,
http://linkedlifedata.com/resource/pubmed/chemical/Flavonoids,
http://linkedlifedata.com/resource/pubmed/chemical/hydroxypropylcellulose
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0918-6158
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1082-5
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9353569-Administration, Intranasal,
pubmed-meshheading:9353569-Animals,
pubmed-meshheading:9353569-Antiviral Agents,
pubmed-meshheading:9353569-Cellulose,
pubmed-meshheading:9353569-Drug Delivery Systems,
pubmed-meshheading:9353569-Female,
pubmed-meshheading:9353569-Flavonoids,
pubmed-meshheading:9353569-Influenza A virus,
pubmed-meshheading:9353569-Lung,
pubmed-meshheading:9353569-Mice,
pubmed-meshheading:9353569-Mice, Inbred BALB C,
pubmed-meshheading:9353569-Nasal Cavity,
pubmed-meshheading:9353569-Orthomyxoviridae Infections,
pubmed-meshheading:9353569-Virus Replication,
pubmed-meshheading:9353569-Viscosity
|
pubmed:year |
1997
|
pubmed:articleTitle |
Enhancement of in vivo anti-influenza virus activity of 5,7,4'-trihydroxy-8-methoxyflavone by drug delivery system using hydroxypropyl cellulose.
|
pubmed:affiliation |
Oriental Medicine Research Center, Kitasato Institute, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|